QT Dispersion in Patients With Systemic Lupus Erythematosus (SLE)

NCT01031797 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 124

Last updated 2009-12-15

No results posted yet for this study

Summary

QT dispersion can be a useful, simple noninvasive method for the early detection of cardiac involvement in SLE patients with active disease. The investigators therefore recommend cardiovascular evaluation for every SLE patient with an SLEDAI higher than 10.

Conditions

Sponsors & Collaborators

  • Shiraz University of Medical Sciences

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2009-03-31
Completion
2009-03-31

Countries

  • Iran

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01031797 on ClinicalTrials.gov